Skip to main content
. 2000 Mar;74(5):2459–2465. doi: 10.1128/jvi.74.5.2459-2465.2000

FIG. 2.

FIG. 2

FIG. 2

Inhibitory effects of WT and mutant AAV genomes on activity of the HPV-16 LCR. (A) Plasmid constructs containing the WT or mutated AAV genome. ITR, inverted terminal repeat. (B) SiHa cells were cotransfected with 10 μg of reporter pBL-16LCR-CAT6 and either 5 μg of vector pBR322 or 10 μg of an effector plasmid (pAV1, pΔAAV1, or pΔKAV1) to yield a molar ratio of 2:1. The data are the means ± standard errors of four individual experiments.